Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BBNX NASDAQ:LIVN NASDAQ:PRCT NYSE:WRBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBNXBeta Bionics$16.40-2.3%$15.71$8.89▼$24.50$729.86MN/A527,705 shs514,719 shsLIVNLivaNova$41.13-2.5%$44.64$32.48▼$57.35$2.30B0.92602,376 shs800,401 shsPRCTPROCEPT BioRobotics$49.96+3.0%$58.32$47.04▼$103.81$2.68B1.071.12 million shs1.28 million shsWRBYWarby Parker$23.61-1.4%$22.29$12.46▼$28.68$2.50B2.091.57 million shs1.52 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBNXBeta Bionics-2.32%+10.51%+15.98%+38.63%+1,639,999,900.00%LIVNLivaNova-2.51%-5.82%-10.74%+11.83%-16.74%PRCTPROCEPT BioRobotics+2.99%-10.34%-14.13%-10.18%-21.10%WRBYWarby Parker-1.23%-3.18%+7.51%+39.70%+43.40%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBBNXBeta Bionics2.3526 of 5 stars4.40.00.00.01.90.80.0LIVNLivaNova2.9483 of 5 stars3.53.00.00.02.11.71.3PRCTPROCEPT BioRobotics2.5398 of 5 stars3.41.00.00.03.42.50.6WRBYWarby Parker2.1031 of 5 stars2.32.00.00.03.43.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBNXBeta Bionics 2.75Moderate Buy$22.5637.53% UpsideLIVNLivaNova 3.00Buy$59.2944.14% UpsidePRCTPROCEPT BioRobotics 2.78Moderate Buy$84.1368.38% UpsideWRBYWarby Parker 2.53Moderate Buy$23.13-2.05% DownsideCurrent Analyst Ratings BreakdownLatest BBNX, PRCT, WRBY, and LIVN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/1/2025WRBYWarby ParkerTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$22.00 ➝ $28.007/30/2025BBNXBeta BionicsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$18.00 ➝ $21.007/30/2025BBNXBeta BionicsRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetNeutral ➝ Neutral$15.00 ➝ $17.007/30/2025WRBYWarby ParkerRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOutperform ➝ Outperform$24.00 ➝ $30.007/15/2025PRCTPROCEPT BioRoboticsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$71.00 ➝ $68.007/10/2025WRBYWarby ParkerJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Perform7/10/2025WRBYWarby ParkerCitizens JmpSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform7/9/2025PRCTPROCEPT BioRoboticsStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$70.007/7/2025PRCTPROCEPT BioRoboticsOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageMarket Perform6/16/2025BBNXBeta BionicsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$26.006/12/2025BBNXBeta BionicsLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Buy$30.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBNXBeta Bionics$65.12M10.95N/AN/A$6.94 per share2.36LIVNLivaNova$1.25B1.79$4.13 per share9.95$24.31 per share1.69PRCTPROCEPT BioRobotics$249.12M11.10N/AN/A$7.71 per share6.48WRBYWarby Parker$771.32M3.20$0.33 per share70.55$3.35 per share7.05Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBNXBeta Bionics-$54.76MN/A0.00∞N/AN/AN/AN/AN/ALIVNLivaNova$63.23M-$4.09N/A13.10N/A-17.41%13.67%6.68%8/6/2025 (Estimated)PRCTPROCEPT BioRobotics-$91.41M-$1.70N/AN/AN/A-36.20%-28.09%-20.02%8/6/2025 (Estimated)WRBYWarby Parker-$20.39M-$0.12N/A236.10N/A-1.79%-2.48%-1.29%8/7/2025 (Confirmed)Latest BBNX, PRCT, WRBY, and LIVN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025WRBYWarby Parker$0.09N/AN/AN/A$212.42 millionN/A8/6/2025Q2 2025LIVNLivaNova$0.84N/AN/AN/A$332.20 millionN/A8/6/2025Q2 2025PRCTPROCEPT BioRobotics-$0.41N/AN/AN/A$75.67 millionN/A7/29/2025Q2 2025BBNXBeta Bionics-$0.51-$0.39+$0.12-$0.39$19.73 million$23.24 million5/6/2025Q1 2025BBNXBeta Bionics-$0.51-$0.52-$0.01-$0.93N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBBNXBeta BionicsN/AN/AN/AN/AN/ALIVNLivaNovaN/AN/AN/AN/AN/APRCTPROCEPT BioRoboticsN/AN/AN/AN/AN/AWRBYWarby ParkerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBNXBeta BionicsN/A14.6814.93LIVNLivaNova0.531.581.37PRCTPROCEPT BioRobotics0.138.957.75WRBYWarby ParkerN/A2.702.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBNXBeta BionicsN/ALIVNLivaNova97.64%PRCTPROCEPT BioRobotics89.46%WRBYWarby Parker93.24%Insider OwnershipCompanyInsider OwnershipBBNXBeta BionicsN/ALIVNLivaNova0.29%PRCTPROCEPT BioRobotics6.60%WRBYWarby Parker18.24%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBNXBeta Bionics29443.47 millionN/AN/ALIVNLivaNova2,90054.53 million54.37 millionOptionablePRCTPROCEPT BioRobotics43055.33 million51.68 millionOptionableWRBYWarby Parker3,780104.50 million85.44 millionOptionableBBNX, PRCT, WRBY, and LIVN HeadlinesRecent News About These CompaniesWarby Parker Inc. (NYSE:WRBY) Sees Significant Growth in Short Interest2 hours ago | marketbeat.comWarby Parker (NYSE:WRBY) Price Target Raised to $28.00August 2 at 8:28 AM | marketbeat.comBlueshift Asset Management LLC Buys New Position in Warby Parker Inc. (NYSE:WRBY)August 2 at 6:21 AM | marketbeat.comWarby Parker (WRBY) to Release Earnings on ThursdayAugust 1 at 6:18 AM | marketbeat.comWarby Parker (NYSE:WRBY) PT Set at $30.00 by Robert W. BairdAugust 1 at 3:35 AM | americanbankingnews.comWarby Parker Inc. (WRBY) Earnings Expected to Grow: Should You Buy?July 31 at 11:06 AM | zacks.comWarby Parker (NYSE:WRBY) Price Target Raised to $30.00July 31 at 10:41 AM | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Buys New Position in Warby Parker Inc. (NYSE:WRBY)July 31 at 4:41 AM | marketbeat.comWarby Parker Inc. (NYSE:WRBY) Receives Consensus Rating of "Moderate Buy" from AnalystsJuly 31 at 3:04 AM | marketbeat.comWarby Parker: Plenty Of Growth Catalysts As Customer Base ExpandsJuly 29, 2025 | seekingalpha.com50,846 Shares in Warby Parker Inc. (NYSE:WRBY) Purchased by Bryce Point Capital LLCJuly 28, 2025 | marketbeat.comBaillie Gifford & Co. Has $33.32 Million Position in Warby Parker Inc. (NYSE:WRBY)July 27, 2025 | marketbeat.comEquitable Trust Co. Sells 13,250 Shares of Warby Parker Inc. (NYSE:WRBY)July 27, 2025 | marketbeat.comZweig DiMenna Associates LLC Has $6.35 Million Stock Holdings in Warby Parker Inc. (NYSE:WRBY)July 26, 2025 | marketbeat.comWarby Parker Inc. (NYSE:WRBY) Shares Purchased by Neo Ivy Capital ManagementJuly 25, 2025 | marketbeat.com2 Cash-Producing Stocks with Competitive Advantages and 1 We Brush OffJuly 24, 2025 | finance.yahoo.comNeil Harris Blumenthal Sells 49,600 Shares of Warby Parker Inc. (NYSE:WRBY) StockJuly 24, 2025 | americanbankingnews.comWarby Parker Inc. (NYSE:WRBY) Shares Purchased by Victory Capital Management Inc.July 24, 2025 | marketbeat.comWarby Parker Inc. (NYSE:WRBY) CEO Neil Harris Blumenthal Sells 49,600 SharesJuly 23, 2025 | marketbeat.comWarby Parker Inc. (NYSE:WRBY) CEO Sells $1,200,816.00 in StockJuly 23, 2025 | insidertrades.comJennison Associates LLC Buys 416,797 Shares of Warby Parker Inc. (NYSE:WRBY)July 20, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBBNX, PRCT, WRBY, and LIVN Company DescriptionsBeta Bionics NASDAQ:BBNX$16.40 -0.39 (-2.32%) As of 08/1/2025 04:00 PM EasternBeta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.LivaNova NASDAQ:LIVN$41.13 -1.06 (-2.51%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$41.10 -0.03 (-0.06%) As of 08/1/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.PROCEPT BioRobotics NASDAQ:PRCT$49.96 +1.45 (+2.99%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$50.94 +0.98 (+1.96%) As of 08/1/2025 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.Warby Parker NYSE:WRBY$23.61 -0.34 (-1.42%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$23.52 -0.09 (-0.36%) As of 08/1/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale Is PG&E an AI Power Play? Why Options Traders Are Betting Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
